0,900  0,003  Aldehyde oxidase inhibitor
0,867  0,004  Caspase 9 stimulant
0,804  0,004  CTGF expression inhibitor
0,787  0,005  Antineoplastic (non-small cell lung cancer)
0,767  0,021  Apoptosis agonist
0,748  0,005  UGT1A9 substrate
0,743  0,005  UGT1A6 substrate
0,713  0,008  Sensitization
0,705  0,005  Antiprotozoal (Leishmania)
0,698  0,014  Antineoplastic (colorectal cancer)
0,696  0,014  Antineoplastic (colon cancer)
0,699  0,021  Antineoplastic (breast cancer)
0,675  0,006  Caspase 3 stimulant
0,682  0,020  Antineoplastic (lung cancer)
0,671  0,014  CYP2C9 substrate
0,663  0,017  Antileukemic
0,658  0,025  Transcription factor NF kappa B inhibitor
0,642  0,012  Aryl hydrocarbon receptor agonist
0,623  0,005  Genotoxic
0,592  0,007  Antimutagenic
0,587  0,015  Mutagenic
0,563  0,017  Antineoplastic (melanoma)
0,559  0,017  CYP1A2 substrate
0,563  0,022  Prostate cancer treatment
0,553  0,012  Antineoplastic (glioma)
0,555  0,019  CYP2C19 substrate
0,556  0,025  Antiprotozoal
0,536  0,010  Antineoplastic (glioblastoma multiforme)
0,556  0,031  15-Lipoxygenase inhibitor
0,529  0,008  Antihypoxic
0,522  0,004  UGT2B15 substrate
0,536  0,019  Antineoplastic (cervical cancer)
0,531  0,018  Antineoplastic (pancreatic cancer)
0,526  0,017  Antioxidant
0,505  0,009  Antineoplastic (renal cancer)
0,488  0,007  Melanin inhibitor
0,506  0,028  Respiratory analeptic
0,495  0,020  Antineoplastic (brain cancer)
0,494  0,021  Cytostatic
0,487  0,020  NOS2 expression inhibitor
0,490  0,024  Antifungal
0,484  0,018  Free radical scavenger
0,478  0,014  UGT2B4 substrate
0,503  0,040  Antibacterial
0,486  0,023  12-Lipoxygenase inhibitor
0,483  0,021  Lipoxygenase inhibitor
0,467  0,010  Antineoplastic (small cell lung cancer)
0,481  0,030  Antineoplastic (ovarian cancer)
0,477  0,028  Cytotoxic
0,470  0,022  Chemopreventive
0,449  0,003  NAD(P)H dehydrogenase (quinone) inhibitor
0,443  0,008  Topoisomerase II inhibitor
0,437  0,005  Aldehyde dehydrogenase inhibitor
0,457  0,027  Carcinogenic
0,447  0,021  Hypoxia-inducible factor 1 alpha inhibitor
0,459  0,034  Ulceration
0,434  0,010  Monophenol monooxygenase inhibitor
0,468  0,047  CYP3A4 substrate
0,501  0,080  Alpha-glucosidase inhibitor
0,434  0,019  Radiosensitizer
0,440  0,029  Apoptosis antagonist
0,428  0,023  DNA damaging
0,421  0,020  Antineoplastic (liver cancer)
0,403  0,005  Cystathionine beta-synthase inhibitor
0,417  0,019  Antihypertriglyceridemic
0,408  0,011  UGT1A3 substrate
0,411  0,018  Pyruvate kinase inhibitor
0,448  0,061  TNF expression inhibitor
0,408  0,025  Superoxide dismutase inhibitor
0,392  0,013  Skin whitener
0,388  0,016  Dual specificity phosphatase inhibitor
0,404  0,038  Radioprotector
0,369  0,010  Protein-tyrosine phosphatase inhibitor
0,402  0,044  Antihypercholesterolemic
0,363  0,004  HIV-1 integrase (3'-Processing) inhibitor
0,371  0,014  Antineoplastic (squamous cell carcinoma)
0,363  0,007  Topoisomerase I inhibitor
0,362  0,007  Carcinogenic, group 2B
0,374  0,020  UGT1A1 substrate
0,364  0,012  Pneumotoxic
0,353  0,005  Histidine decarboxylase inhibitor
0,362  0,014  Tubulin antagonist
0,381  0,035  CYP1A2 inhibitor
0,392  0,048  FMO1 substrate
0,366  0,031  Antineoplastic (osteosarcoma)
0,337  0,003  Aldehyde dehydrogenase substrate
0,339  0,004  Alcohol dehydrogenase substrate
0,365  0,034  Antineoplastic (lymphoma)
0,334  0,005  Topoisomerase II alpha inhibitor
0,372  0,044  Analeptic
0,375  0,047  AR expression inhibitor
0,349  0,023  GST M1-1 substrate
0,352  0,026  UDP-glucuronosyltransferase substrate
0,340  0,015  Interferon gamma antagonist
0,393  0,070  GST A substrate
0,341  0,019  UGT2B7 substrate
0,326  0,005  Beta tubulin antagonist
0,326  0,004  HIV-1 integrase (Strand Transfer) inhibitor
0,337  0,018  Antineoplastic (carcinoma)
0,321  0,004  Alpha tubulin antagonist
0,340  0,024  UGT1A4 substrate
0,405  0,096  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,318  0,009  UGT2B9 substrate
0,320  0,014  Protein kinase stimulant
0,332  0,029  Antineoplastic (sarcoma)
0,314  0,012  Heat shock protein 90 alpha antagonist
0,355  0,054  Antimycobacterial
0,333  0,034  DNA synthesis inhibitor
0,306  0,007  Antibacterial (Helicobacter pylori)
0,301  0,005  UGT2B10 substrate
0,317  0,021  Antiseptic
0,346  0,053  Cardioprotectant
0,302  0,010  Antifungal enhancer
0,338  0,046  Antineoplastic (multiple myeloma)
0,299  0,010  Heat shock protein 90 antagonist
0,322  0,033  Antineoplastic (bladder cancer)
0,321  0,036  Nitric oxide antagonist
0,289  0,010  Antineoplastic antibiotic
0,286  0,009  Xanthine oxidase inhibitor
0,338  0,063  CYP2D6 substrate
0,285  0,012  Protein-tyrosine phosphatase 1B inhibitor
0,295  0,025  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,278  0,010  Expectorant
0,329  0,062  NOS3 expression inhibitor
0,277  0,011  Gout treatment
0,309  0,043  Amyloid beta aggregation inhibitor
0,354  0,089  CYP2C19 inhibitor
0,288  0,024  Skin irritative effect
0,285  0,022  MAO inhibitor
0,267  0,007  Toll-Like receptor 2 antagonist
0,310  0,050  Transcription factor STAT inhibitor
0,268  0,009  Mannose-6-phosphate isomerase inhibitor
0,275  0,021  Phospholipase C inhibitor
0,257  0,006  Xanthine oxidase substrate
0,306  0,055  Chemoprotective
0,311  0,061  Antituberculosic
0,322  0,073  Immunostimulant
0,275  0,026  Neurotrophic factor enhancer
0,261  0,014  5-Lipoxygenase inhibitor
0,271  0,025  Carcinogenic, group 3
0,337  0,093  GABA C receptor rho-3 antagonist
0,292  0,049  5 Hydroxytryptamine uptake stimulant
0,319  0,080  Cholesterol antagonist
0,275  0,037  Hepatoprotectant
0,257  0,020  Succinate dehydrogenase inhibitor
0,275  0,038  RNA-directed DNA polymerase inhibitor
0,276  0,040  Anesthetic general
0,265  0,031  Mcl-1 antagonist
0,254  0,020  MAO A inhibitor
0,289  0,056  Proliferative diseases treatment
0,258  0,025  Lipid peroxidase inhibitor
0,291  0,059  Antipyretic
0,235  0,008  Mucolytic
0,290  0,064  Teratogen
0,261  0,037  Dual specificity phosphatase 3 inhibitor
0,314  0,091  Antiprotozoal (Plasmodium)
0,242  0,018  Aldose reductase substrate
0,323  0,100  CYP2C9 inhibitor
0,231  0,009  Porphobilinogen synthase inhibitor
0,263  0,041  DNA methyltransferase I inhibitor
0,275  0,054  Antineoplastic (lymphocytic leukemia)
0,241  0,023  Aldehyde oxidase substrate
0,234  0,018  DNA intercalator
0,235  0,020  Antianemic
0,321  0,107  Antipruritic, allergic
0,274  0,061  Antiamyloidogenic
0,227  0,015  Sulfotransferase substrate
0,253  0,045  VCAM1 expression inhibitor
0,255  0,046  Peroxidase inhibitor
0,321  0,113  Histamine release inhibitor
0,238  0,030  Muscular dystrophy treatment
0,227  0,020  Alkylator
0,222  0,017  Antihemorrhagic
0,334  0,130  5 Hydroxytryptamine release inhibitor
0,297  0,094  Calcium channel activator
0,248  0,049  DNA methylase inhibitor
0,254  0,058  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,203  0,008  Macrophage migration inhibitory factor inhibitor
0,234  0,042  Antipruritic, non-allergic
0,209  0,017  SULT1A1 substrate
0,255  0,063  Tyrosine 3 hydroxylase inhibitor
0,214  0,025  Antirickettsial
0,210  0,023  MAO B inhibitor
0,286  0,100  Angiogenesis inhibitor
0,189  0,005  Purinergic P2X2 antagonist
0,255  0,071  Embryotoxic
0,194  0,011  Antineoplastic (uterine cancer)
0,230  0,048  Insulin sensitizer
0,191  0,010  Estrogen receptor beta antagonist
0,183  0,004  Granulocyte macrophage colony stimulating factor agonist
0,254  0,077  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,181  0,009  Estrogen receptor alpha antagonist
0,187  0,015  Estrogen antagonist
0,178  0,010  Aromatase inhibitor
0,209  0,041  Amylase inhibitor
0,250  0,083  Transcription factor STAT3 inhibitor
0,235  0,068  Antihypotensive
0,289  0,122  Immunosuppressant
0,171  0,004  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,243  0,078  Antidiabetic symptomatic
0,189  0,024  Movement disorders treatment
0,209  0,044  VEGF expression inhibitor
0,170  0,009  UGT2B11 substrate
0,197  0,036  Carcinogenic, group 1
0,177  0,016  Beta glucuronidase inhibitor
0,172  0,012  DOPA decarboxylase inhibitor
0,181  0,022  Coagulant
0,323  0,165  Antineoplastic (solid tumors)
0,161  0,005  Estradiol 17 beta-dehydrogenase inhibitor
0,161  0,006  Purinergic P2X1 antagonist
0,198  0,045  Antiviral (Influenza A)
0,203  0,050  3C-like protease (Human coronavirus) inhibitor
0,166  0,017  Ca2+-transporting ATPase inhibitor
0,153  0,005  Topoisomerase II beta inhibitor
0,161  0,013  Antifungal (Pneumocystis)
0,190  0,043  Arachidonic acid antagonist
0,154  0,007  GABA aminotransferase inhibitor
0,164  0,017  Carcinogenic, group 2A
0,188  0,043  Hexokinase inhibitor
0,184  0,040  Alkaline phosphatase inhibitor
0,186  0,042  Antidiarrheal
0,219  0,076  Antiulcerative
0,182  0,039  SULT1A3 substrate
0,233  0,092  Interleukin agonist
0,217  0,076  Antiparasitic
0,189  0,050  Antineoplastic (bone cancer)
0,163  0,024  Photosensitizer
0,146  0,008  Xanthine dehydrogenase inhibitor
0,152  0,015  Antiviral (Trachoma)
0,177  0,045  GABA C receptor rho-2 antagonist
0,209  0,077  Antialcoholic
0,199  0,068  Antihelmintic
0,187  0,056  Eye irritation, high
0,158  0,028  Contraceptive female
0,155  0,028  TRPA1 agonist
0,146  0,021  Telomerase inhibitor
0,198  0,073  Abortion inducer
0,152  0,032  Sphingosine 1-phosphate receptor 4 antagonist
0,140  0,024  Carbonic anhydrase XIII inhibitor
0,150  0,034  Papain-like protease (SARS coronavirus) inhibitor
0,125  0,010  CDC25B inhibitor
0,136  0,021  Phosphofructokinase-1 inhibitor
0,136  0,022  Thioredoxin inhibitor
0,125  0,013  HIV-1 integrase inhibitor
0,136  0,024  Protein kinase C zeta inhibitor
0,117  0,006  Potassium channel Kv1.3 blocker
0,150  0,041  Glutathione S-transferase substrate
0,181  0,073  LIM domain kinase 1 inhibitor
0,244  0,135  Sodium/bile acid cotransporter inhibitor
0,163  0,055  CF transmembrane conductance regulator agonist
0,145  0,037  GST P1-1 substrate
0,208  0,100  Cardiovascular analeptic
0,159  0,052  Neurotrophic factor
0,115  0,008  CD45 antagonist
0,187  0,083  Antiviral (Influenza)
0,119  0,017  Thioredoxin reductase inhibitor
0,132  0,029  Anabolic
0,206  0,104  Antiviral (West Nile virus)
0,121  0,019  CDC25A inhibitor
0,138  0,038  Caspase 3 inhibitor
0,186  0,087  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,211  0,112  5 Hydroxytryptamine release stimulant
0,101  0,004  Pregnane X receptor antagonist
0,117  0,022  Keratolytic
0,098  0,004  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,129  0,035  Creatine kinase inhibitor
0,133  0,040  Transcription factor STAT6 inhibitor
0,129  0,038  UDP-glucose 4-epimerase inhibitor
0,130  0,039  UGT2B1 substrate
0,102  0,012  Antimycoplasmal
0,147  0,057  Acetylcholinesterase inhibitor
0,237  0,147  Vasodilator, coronary
0,136  0,047  DNA repair enzyme inhibitor
0,138  0,049  Interleukin 1b antagonist
0,118  0,031  SULT1E1 substrate
0,094  0,007  Glucose-6-phosphate translocase inhibitor
0,104  0,017  Aldose reductase inhibitor
0,091  0,005  Inosine monophosphate dehydrogenase inhibitor
0,166  0,081  Phobic disorders treatment
0,110  0,026  Glutamate dehydrogenase inhibitor
0,113  0,030  CYP2A6 inhibitor
0,174  0,094  CYP2B6 inhibitor
0,110  0,030  Antibiotic
0,119  0,040  Breast cancer-resistant protein inhibitor
0,135  0,056  Adenylate cyclase inhibitor
0,125  0,046  HDL-cholesterol increasing
0,171  0,095  Non-steroidal antiinflammatory agent
0,114  0,039  Alcohol dehydrogenase inhibitor
0,261  0,186  DNA polymerase beta inhibitor
0,197  0,122  Spasmolytic
0,138  0,064  Toll-Like receptor antagonist
0,135  0,062  Antihyperlipoproteinemic
0,187  0,114  Nitric-oxide synthase stimulant
0,121  0,050  NAT2 substrate
0,217  0,146  Prostaglandin dehydrogenase inhibitor
0,097  0,027  SULT1A2 substrate
0,173  0,104  Cardiodepressant
0,110  0,042  Antineoplastic alkaloid
0,119  0,052  Antihelmintic (Fasciola)
0,098  0,032  D-Ala-D-Ala ligase inhibitor
0,116  0,051  Antiprotozoal (Toxoplasma)
0,131  0,068  Alpha-N-acetylglucosaminidase inhibitor
0,132  0,069  Antiprotozoal (Trichomonas)
0,116  0,053  Electron transport complex I inhibitor
0,251  0,191  DNA directed DNA polymerase inhibitor
0,103  0,045  Paget's disease treatment
0,132  0,074  Interleukin 1 antagonist
0,109  0,052  Dementia treatment
0,121  0,065  Cholesterol synthesis inhibitor
0,101  0,046  Androgen antagonist
0,139  0,083  Adenylate cyclase stimulant
0,204  0,149  Bone diseases treatment
0,079  0,025  Alcohol oxidase inhibitor
0,105  0,051  Vascular dementia treatment
0,084  0,031  Dopamine D1 antagonist
0,112  0,060  Protein kinase C gamma inhibitor
0,253  0,202  Calcium channel L-type activator
0,058  0,007  Catechol O-methyltransferase inhibitor
0,212  0,162  Thioredoxin glutathione reductase inhibitor
0,104  0,054  Antineoplastic, alkylator
0,138  0,089  Phospholipase A2 inhibitor
0,115  0,066  Microtubule formation inhibitor
0,186  0,138  Antiosteoporotic
0,059  0,011  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,089  0,042  Na+ K+ transporting ATPase inhibitor
0,093  0,046  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,096  0,049  Glutamate release inhibitor
0,056  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,136  0,090  Heat shock protein 70 antagonist
0,106  0,060  Carbonic anhydrase XV inhibitor
0,227  0,181  Antineoplastic (endocrine cancer)
0,075  0,029  Neuraminidase (influenza) inhibitor
0,071  0,026  Estrogen agonist
0,076  0,031  Protease 3C (Human rhinovirus) inhibitor
0,071  0,027  Heat shock protein 90 beta antagonist
0,065  0,021  DNA helicase inhibitor
0,163  0,120  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,047  0,005  Inosine monophosphate dehydrogenase 2 inhibitor
0,121  0,081  NADPH oxidase inhibitor
0,082  0,042  Cathepsin G inhibitor
0,090  0,050  Antispirochetal
0,070  0,030  Transcription factor RelA inhibitor
0,100  0,062  Carbonic anhydrase III inhibitor
0,091  0,054  Ornithine decarboxylase inhibitor
0,119  0,083  Anesthetic
0,076  0,040  Peroxisome proliferator-activated receptor gamma antagonist
0,178  0,141  Antiprotozoal (Trypanosoma)
0,091  0,055  Antidote, mercury
0,175  0,141  Calpain inhibitor
0,063  0,029  Ryanodine receptor antagonist
0,072  0,039  Glutamate (mGluR7) antagonist
0,124  0,091  Antieczematic
0,089  0,058  NADH dehydrogenase inhibitor
0,073  0,042  Leukotriene synthesis inhibitor
0,135  0,105  Antihelmintic (Nematodes)
0,118  0,088  Bone formation stimulant
0,070  0,044  SULT2A1 substrate
0,099  0,072  AMP-activated protein kinase stimulant
0,057  0,031  Leukotriene B4 antagonist
0,077  0,052  Narcotic antagonist
0,039  0,015  Nucleoside transporters inhibitor
0,028  0,004  Antibiotic Anthracycline-like
0,120  0,096  Acaricide
0,059  0,036  Postcoital contraceptive
0,087  0,064  Actinic keratosis treatment
0,034  0,011  Protein 30S ribosomal subunit inhibitor
0,025  0,003  Antibiotic Tetracycline-like
0,124  0,102  Antiprotozoal (Coccidial)
0,074  0,052  NAT1 substrate
0,082  0,061  Estrogen-related receptor beta agonist
0,073  0,052  Glutamate decarboxylase inhibitor
0,042  0,022  Progesterone antagonist
0,203  0,185  Calpain 2 inhibitor
0,051  0,035  Anesthetic inhalation
0,114  0,099  Antianorexic
0,085  0,071  HIV-1 integrase (Overall Integration) inhibitor
0,036  0,022  Estrogen receptor beta agonist
0,034  0,020  GABA transporter 3 inhibitor
0,059  0,045  Cyclin D1 inhibitor
0,058  0,046  Bcl-xL inhibitor
0,070  0,058  Arylamine N-Acetyltransferase substrate
0,039  0,028  Dopamine D3 agonist
0,166  0,155  Peptidyltransferase inhibitor
0,052  0,041  Protein kinase C eta inhibitor
0,179  0,169  Flavin-containing monooxygenase substrate
0,057  0,047  Neuraminidase inhibitor
0,046  0,037  Plasminogen activator inhibitor antagonist
0,105  0,096  Cyclooxygenase 3 inhibitor
0,092  0,084  Excitatory amino acid transporter EAAC1 inhibitor
0,055  0,046  Botulinum neurotoxin type A inhibitor
0,088  0,081  GABA C receptor rho-1 antagonist
0,083  0,077  Uric acid excretion stimulant
0,043  0,036  Neuraminidase (Influenza A) inhibitor
0,054  0,048  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,059  0,053  Leukotriene antagonist
0,021  0,016  Leukotriene B4 receptor 2 antagonist
0,050  0,046  Cyclin B2 inhibitor
0,018  0,014  Granulocyte colony stimulating factor receptor agonist
0,049  0,046  Postmenopausal disorders treatment
0,054  0,051  TRPA1 antagonist
0,080  0,077  Triose-phosphate isomerase inhibitor
0,029  0,027  ATP citrate lysase inhibitor
0,030  0,028  Estrogen-related receptor beta antagonist
0,030  0,029  Glutamate (mGluR3) agonist
0,045  0,043  Dihydroorotate dehydrogenase inhibitor
0,111  0,110  Vanilloid 1 agonist

